Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 77Brain Neoplasms 75Glioma 68Astrocytoma 30Central Nervous System Neoplasms 24Gliosarcoma 21Neuroblastoma 19Lung Neoplasms 19Ependymoma 19Medulloblastoma 18Oligodendroglioma 17Meningioma 16Breast Neoplasms 15Neoplasm Metastasis 12Carcinoma, Non-Small-Cell Lung 10Sarcoma 7Neuroendocrine Tumors 7Neuroectodermal Tumors, Primitive, Peripheral 7Melanoma 7Glioma, Subependymal 7Ganglioneuroblastoma 7Wilms Tumor 6Thyroid Neoplasms 6Rhabdoid Tumor 6Osteosarcoma 6Neuroectodermal Tumors, Primitive 6Meningeal Carcinomatosis 6Lymphoma, Non-Hodgkin 6Lymphoma 6Histiocytosis, Langerhans-Cell 6

Interventions

Tissue Array Analysis 1Magnetic Resonance Spectroscopy 1Ferrosoferric Oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhagic Stroke × Magnetic Resonance Spectroscopy × CNS × Clear all
NCT02452216 2017-08-31

Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS

Stanford University

Phase EARLY_PHASE1 Completed
10 enrolled
CNS

Ischemic Stroke, Hemorrhagic Stroke, Brain Injuries, Brain Neoplasms, Central Nervous System Infections, Neurodegenerative Diseases, Central Nervous System Vascular Malformations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡